Jump to content
Comments are closed. Still search and read. Click this red line for lots of support - phone numbers for prostate cancer nurses, psychologist, an advanced man, local groups, depression support, several online and Facebook groups, videos. (JimJimJimJim.com)

Researchers halt study early on Bayer’s Xofigo combo study.

Geoff Buttfield

By Geoff Buttfield
in Articles on other sites

Recommended Posts

Geoff Buttfield Newbie

Geoff Buttfield

Posted
Posted

Researchers halt study early on Bayer’s Xofigo combo study early on safety alert.

Back in the spring of 2016, researchers reported that a combination of Bayer’s Xofigo (radium-223) with Zytiga (abiraterone) came through with evidence of significantly reduced bone pain for men suffering from prostate cancer. But scientists were forced to unblind the Phase III pivotal trial prematurely.

For further details click on the link below.

https://buff.ly/2izbr5f

Link to comment
Share on other sites

Archived

This topic is now archived and is closed to further replies.

Go to topic listing
×
×
  • Create New...